Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary intervention

Mahn‐Won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Kiyuk Chang(St. Mary's Hospital), Ki‐Bae Seung, Doo Soo Jeon(Catholic University of Korea), Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital), Suk Min Seo(The Catholic University of Korea Incheon St. Mary's Hospital), Pum-Joon Kim(The Catholic University of Korea Seoul St. Mary's Hospital), Hun‐Jun Park(Soonchunhyang University), Chan Joon Kim(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Ho-Sook Kim(Inje University Busan Paik Hospital), Dong‐Bin Kim(St. Paul's Hospital), Sung‐Ho Her(St. Mary's Hospital), Jong Min Lee(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Wook-Sung Chung, Yunseok Choi(University of Ulsan), Chul‐Soo Park(Catholic University of Korea), Yoon‐Seok Koh(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Dong Il Shin(The Catholic University of Korea Incheon St. Mary's Hospital), Jae‐Gook Shin(Inje University)
Pharmacogenetics and Genomics
August 6, 2013
Cited by 18


Related Papers